On the 21st April 2021, we launched our first PSYCH Investor Summit: Europe & Asia for a day of networking, pitches and keynotes.
The PSYCH Investor Summit: Europe & Asia saw distinguished industry leaders, rising entrepreneurs and global psychedelics investors engaging via our virtual event platform – sharing insights and developing this emerging frontier.
This global psychedelics industry event showcased expanding businesses looking for capital – delivering the industry’s most promising opportunities directly to investors & funds.
Over this six hour event, the PSYCH Investor Summit: Europe & Asia facilitated hundreds of connections and meetings, including a passionate roundtable discussion with presenting CEO’s and the audience of global investors.
Professor David Nutt
Head of Research, Awakn Life Sciences
Professor David Nutt will guide our audience through the exciting developments within the industry and the pioneering research across Psychedelic Medicine in Europe.
Ronan Levy Co-Founder & Executive Chairman, Field Trip Health Ltd.
Anthony Tennyson Chief Executive Officer, Awakn Life Sciences
Peter Reitano Chief Executive Officer, Gwella
Nick Murray Co-Founder & Chief Executive Officer, Wake Network